Evaxion Biotech A/S ADR (EVAX) Stock Price, Quote & News

Company Profile

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a m...

Industry: Biotechnology

Sector: Healthcare

Phone: 45 53 53 18 50

Website: evaxion.ai

Address:

Dr. Neergaards Vej, 5th Floor, Horsholm, Denmark

Lenni_D Jul. 1 at 12:13 PM

$EVAX https://evaxion.ai/investors/press-releases/?press_release_id=11226 Blah blah. Wake us up when you have a deal. Nothing but great science and no deals here. This can explode on a couple of deals or it can die a slow death. Amazing pipeline but no Pharma or large biotech is biting so far.

0 · Reply

STACKD0E Jul. 1 at 12:10 PM

$LGO $BTQ $ALM $HIND $EVAX ✨️

0 · Reply

It_S_Me Jun. 29 at 7:20 PM

$EVAX evax is huge opportunity

0 · Reply

topstockalerts Jun. 26 at 11:46 PM

After Hours Top Gainers PT2 $QH $EVAX $BATL $REFR $YDKG

0 · Reply

Tradezeez Jun. 19 at 2:33 PM

$EVAX Back into the abyss we go…

0 · Reply

Manwiththeplan Jun. 16 at 8:02 PM

$EVAX and again -5%

1 · Reply

focafoca99 Jun. 12 at 7:17 AM

$EVAX earned the 2026 Prix Galien UK Award for Best digital health solution.

1 · Reply

BioTuesdays Jun. 11 at 4:57 PM

$EVAX has announced new preclinical data for EVX-04, an AI-designed off-the-shelf therapeutic vaccine for acute myeloid leukemia (AML) that targets multiple endogenous retrovirus (ERV) tumor antigens from the dark genome. https://biotuesdays.com/2026/06/11/evaxion-presents-new-data-for-off-the-shelf-aml-vaccine/

0 · Reply

Whtmtn Jun. 11 at 1:34 PM

$EVAX like this as a high beta bio play. Ai will help biotech immensely.

1 · Reply

focafoca99 Jun. 11 at 6:13 AM

$EVAX reveals new preclinical data for its off‑the‑shelf AML vaccine EVX‑04, presented at the EHA 2026 congress.

2 · Reply

Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop

Jun 12, 2026, 3:00 AM EDT - 22 days ago

Evaxion receives Prix Galien UK Award for Best digital health solution

Jun 11, 2026, 2:00 AM EDT - 23 days ago

Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia

May 12, 2026, 9:30 AM EDT - 7 weeks ago

Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress

May 7, 2026, 8:30 AM EDT - 2 months ago

Evaxion Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 2 months ago

Evaxion Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 2 months ago

Evaxion Slides: Q1 2026

May 7, 2026, 7:30 AM EDT - 2 months ago

Evaxion announces business update and first quarter 2026 financial results

May 4, 2026, 8:00 AM EDT - 2 months ago

Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026

2026-04-27T16:25:27.000Z - 2 months ago

Evaxion Biotech management to meet with Maxim

Apr 27, 2026, 8:00 AM EDT - 2 months ago

Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer

2026-04-17T19:15:15.000Z - 2 months ago

Evaxion says EVX-01 demonstrates 86% vaccine target precision in trial

Apr 17, 2026, 3:10 PM EDT - 2 months ago

Evaxion's AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial

2026-04-17T19:05:59.000Z - 2 months ago

Evaxion Biotech announces new data to be presented at AACR meeting

Apr 16, 2026, 11:30 AM EDT - 2 months ago

Evaxion concludes Annual General Meeting

2026-04-07T12:55:09.000Z - 3 months ago

Evaxion Biotech reports last patient visit in one-year extension of EVX-01 trial

MRK

Mar 30, 2026, 8:00 AM EDT - 3 months ago

Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress

Mar 19, 2026, 9:00 AM EDT - 3 months ago

Notice to convene Evaxion's Annual General Meeting

2026-03-09T20:11:13.000Z - 4 months ago